Skip to content

A Comparison of Manufacturing Processes for AIR OPTIX® COLORS Contact Lens

AIR OPTIX® COLORS: Automated vs Semi-automated Manufacturing Processes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01614678
Enrollment
49
Registered
2012-06-08
Start date
2012-06-30
Completion date
2012-08-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

myopia

Brief summary

The purpose of this feasibility study was to compare AIR OPTIX® COLORS contact lenses manufactured using an automated process to AIR OPTIX® COLORS contact lenses manufactured using a semi-automatic process.

Interventions

DEVICELotrafilcon B contact lens with color, automated

Silicone hydrogel contact lens with color manufactured via an automated process

DEVICELotrafilcon B contact lens with color, semi-automated

Silicone hydrogel contact lens with color manufactured via a semi-automated process

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able and willing to sign a written Informed Consent form. * Cylinder ≤ -0.75 diopter (D). * Able to achieve visual acuity (VA) of at least 20/30 Snellen in each eye at distance with contact lenses (CLCVA) and best corrected visual acuity (BCVA) ≥ 20/25. * Have spectacles that provide acceptable vision and be willing to wear them if unable to wear the study lenses. * Successful daily wear of single-vision spherical soft contact lenses in both eyes during the past 3 months for a minimum of 8 hours/day, 5 days/week. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Eye injury or surgery within twelve weeks immediately prior to enrollment in this trial. * Pre-existing ocular irritation that would preclude contact lens fitting. * Currently enrolled in an ophthalmic clinical trial. * Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions, as determined by the investigator. * Pathologically dry eye. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Overall satisfactionWeek 2The participant was asked, Please rate your overall satisfaction based on your experience with the study lenses over the last 2 weeks. When considering your rating, please take into account comfort, vision, and handling, but disregard the appearance of the lenses. Overall satisfaction was rated on a scale of 1-10, with 1=Not at all satisfied, and 10=Completely satisfied.

Secondary

MeasureTime frameDescription
Overall lens fitDispense (Day 0)Overall lens fit was assessed by the investigator on a 5-point scale, with +2=Unacceptably loose, +1=Acceptably loose, 0=Optimal, -1=Acceptably tight, -2=Unacceptably tight.
Contact Lens Corrected Visual Acuity (CLCVA)Dispense (Day 0)CLCVA (corrected distance monocular visual measurement in normal illumination) was tested for each eye individually while wearing study lenses. Participant read a Snellen chart distant to the participant in normal lighting, with 20/20 Snellen acuity considered normal distance eyesight.
Corrected distance monocular visual measurement in normal illumination reported as Contact Lens Corrected Visual Acuity (CLCVA)Week 2As tested for each eye individually while wearing study lenses. Participant will read a Snellen chart distant to the participant in normal lighting, with 20/20 Snellen acuity considered normal distance eyesight.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026